A Phase 3b, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects with Immun
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
DOVA Pharmaceuticals
Start Date
March 18, 2021
End Date
January 3, 2024
Administered By
Pediatrics, Hematology-Oncology
Awarded By
DOVA Pharmaceuticals
Start Date
March 18, 2021
End Date
January 3, 2024